| | | | | |
HIO Western Asset High Income Opportunity Fund, Inc. | $3,6300 | +0,00 % | $345,21M | $260,61K | |
SORN Soren Acquisition Corp. Class A Ordinary Shares | $9,9400 | +0,00 % | $344,55M | $16,80K | |
SSSS SuRo Capital Corp. Common Stock | $13,2400 | +0,23 % | $344,38M | $281,74K | |
BCML BayCom Corp Common Stock | $31,4300 | -0,38 % | $344,18M | $131,14K | |
PRLD Prelude Therapeutics Incorporated | $4,3150 | -0,12 % | $344,06M | $262,12K | |
HPF John Hancock Preferred Income Fund II | $15,8900 | +0,00 % | $344,03M | $28,94K | |
GLSI Greenwich LifeSciences, Inc. | $23,6900 | +1,33 % | $343,17M | $77,04K | |
FNLC First Bancorp, Inc. (ME) | $30,3800 | +0,00 % | $342,55M | $30,65K | |
RM REGIONAL MANAGEMENT CORP | $37,2000 | +0,00 % | $342,54M | $30,87K | |
HCMA HCM III Acquisition Corp. Class A Ordinary Share | $10,2650 | -0,15 % | $342,39M | $5,50K | |
| $4,0700 | +0,00 % | $342,23M | $689,56K | |
CHMG Chemung Financial Corp | $70,8500 | -0,17 % | $342,06M | $87,90K | |
DSAC Daedalus Special Acquisition Corp. Class A Ordinary Shares | $10,0500 | +0,00 % | $341,88M | $3,30K | |
CURR Currenc Group Inc. Ordinary Shares | $3,0400 | +0,33 % | $340,21M | $184,16K | |
UPB Upstream Bio, Inc. Common Stock | $6,2350 | -0,24 % | $340,12M | $601,79K | |
